TRACON Pharmaceuticals (NASDAQ:TCON) Inc said it has ended its fiscal year 2021 with cash and equivalents of $24.1 million as of December 31, 2021, as the company outlined some key milestones for the coming year. DTC eligibility will simplify the process of trading and transferring common shares, enhancing liquidity in the United States by accelerating the settlement period for transfers and reducing costs for investors. Trading on OTCQB will contribute to our strategy to continue to enhance our share liquidity and broaden the reach and awareness of our digital health software solutions, so that everyone gets the best care." The company also announced that its common shares have been approved for eligibility for book-entry and depository services through the Depository Trust Company (DTC) in the US, which will facilitate electronic clearing and settlement of transfers of Common Shares.
Sachin Aggarwal, Think Research (TSX-V:THNK) ( Think Research (TSX-V:THNK)) CEO said: "Posting Think's common shares for trading on the OTCQB is a first step to provide easier access and trading capability in our shares for both institutional and retail investors. Think's common shares commenced trading on the OTCQB under the symbol THKKF at the open on March 15, 2022, and will continue to trade on the TSX Venture Exchange under the symbol THNK. Think Research (TSX-V:THNK) Corporation has announced that its common shares have been approved for trading on the OTCQB Venture Market in the United States, operated by the OTC Markets Group.
0 kommentar(er)
